Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Author(s):
Dewint, P.; Hansen, B.E.; Verhey, E.; Oldenburg, B.; Hommes, D.W.; Pierik, M.; Ponsioen, C.I.J.; Dullemen, H.M. van; Russel, M.; Bodegraven, A.A. van; Woude, C.J. van der
Published
2014
Publication type
Article / Letter to editor
CROHN'S DISEASEANTIBIOTIC THERAPYINFLAMMATORY BOWEL DISEASE
Date issued
2014-02-28
Language
English
Is part of
Gut (2014), Vol. 63, no. 2, p. 292-299
hdl
1887/117385
doi
10.1136/gutjnl-2013-304488